VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE
Abstract
Background. Hepatitis B virus (HBV) infection remains a global public health problem. Objective – to analyze the prevalence of viral coinfections with human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis delta virus (HDV), TT-viruses and SENV in patients with chronic hepatitis B (CHB) and to assess their influence on liver disease severity. Material and methods. The observational cross-sectional study included 287 patients with chronic hepatitis B virus (HBV) – those with monoinfection and coinfected with HIV, HCV, HDV. Routine hematological and biochemical tests were performed, serum HBV DNA level as well as liver fibrosis stage were measured. Blood samples from 62 patients for Torque teno virus (TTV), Torque teno mini virus, Torque teno midi virus, SENV (D and H genotypes) DNAs were examined by polymerase chain reaction. Results. Among patients with CHB the prevalence of coinfection HBV + HIV is 6.6%, HBV + HCV – 6.3%, HBV + HDV – 3.8% and HBV + HDV + HCV – 1.7%. CHB patients coinfected with HIV, HCV, HDV had more pronounced biochemical differences and higher proportion of liver cirrhosis vs. HBV-monoinfected ones. The detection rate of TT viruses and their various combinations in patients with CHB is 91.9%, SENV – 66.1%. Conclusion. Coinfection with HIV, HCV, HDV in CHB patients is associated with more severe forms of chronic liver disease as compared to HBV-monoinfection. TT viruses and SENV are widespread and don’t affect the severity of liver disease in patients with CHB.References
World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. 83 p.
World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015. 166 p.
Nguyen T, Sterling R. Viral hepatitis B coinfection with human immunodeficiency virus, hepatitis D virus, or hepatitis C virus. Clinical Liver Disease. 2013;2(1):45-48. https://doi.org/10.1002/cld.146.
Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31(15):2035-2052. https://doi.org/10.1097/QAD.0000000000001574.
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-398. https://doi.org/10.1016/j.jhep.2017.03.021.
Terrault NA, Lok AS, McMahon BJ, Chang K-M, Hwang JP, Jonas MM, Brown Jr. RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560-1599. https://doi.org/10.1002/hep.29800.
Miao Z, Zhang S, Ou X, Li S, Ma Z, Wang W, Peppelenbosch MP, Liu J, Pan Q. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020;221(10):1677-1687. https://doi.org/10.1093/infdis/jiz633.
Botelho-Souza LF, Vasconcelos MPA, dos Santos AO, Salcedo JMV, Vieira DS. Hepatitis delta: virological and clinical aspects. Virol J. 2017;14(1):177. https://doi.org/10.1186/s12985-017-0845-y.
Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viral interactions and management. Ann Gastroenterol. 2015;28(2):221-228.
Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol. 2014;20(40):14559-14567. https://doi.org/10.3748/wjg.v20.i40.14559.
Spandole S, Cimponeriu D, Berca LM, Mihăescu G. Human anelloviruses: an update of molecular, epidemiological and clinical aspects. Arch Virol. 2015;160:893-908. https://doi.org/10.1007/s00705-015-2363-9.
Reshetnyak VI, Maev IV, Burmistrov AI, Chekmazov IA, Karlovich TI. Torque teno virus in liver diseases: On the way towards unity of view. World J Gastroenterol. 2020;26(15):1691-1707. https://doi.org/10.3748/wjg.v26.i15.1691.
Sagir A, Kirschberg O, Heintges T, Erhardt A, Häussinger D. SEN virus infection. Rev Med Virol. 2004;14(3):141-148. https://doi.org/10.1002/rmv.421.
Kazemi MJ, Yaghobi R, Iravani Saadi M, Geramizadeh B, Moayedi J. Association between TT virus infection and cirrhosis in liver transplant patients. Hepat Mon. 2015;15(9):e28370. https://doi.org/10.5812/hepatmon.28370.
Elsherbiny NM, Hassan EA, Ahmed AO, El-Rehim AS, Rehim NA, Hassany SM. Does SEN virus (SENV) infection affect the progression of chronic hepatitis C or B among Egyptian patients. African J Microbiol Res. 2015;9(23):1504-1512. https://doi.org/10.5897/AJMR2014.7242.
1.png)
